Search research articles
Contact Us
Filters
Showing results (131-140 of 195) with videos related to
Page
of 20
Sort By:
Journal of Crohn'S & Colitis
|
April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Sailish Honap, Desmond Chee, Thomas P Chapman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2019
Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease
Kirstin M Taylor, Ken B Hanscombe, Natalie J Prescott, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 6, 2018
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All
Gil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, et al.
Gastroenterology
|
February 3, 2019
Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α
Rimma Goldberg, Cristiano Scotta, Dianne Cooper, et al.
Digestive Diseases and Sciences
|
January 27, 2025
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study
Sailish Honap, Bénédicte Caron, Jacob E Ollech, et al.
The American Journal of Gastroenterology
|
July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease
Hannah K Systrom, Victoria Rai, Siddharth Singh, et al.
BMJ Open Gastroenterology
|
January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Gastroenterology
|
October 6, 2019
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial
Selina R Cox, James O Lindsay, Sébastien Fromentin, et al.
Digestive Diseases and Sciences
|
January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Gaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Nature Immunology
|
November 14, 2018
The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
Daisy Melandri, Iva Zlatareva, Raphaël A G Chaleil, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 195) with videos related to
Sort By:
Page
of 20
Journal of Crohn'S & Colitis
|
April 14, 2020
Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
Sailish Honap, Desmond Chee, Thomas P Chapman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2019
Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease
Kirstin M Taylor, Ken B Hanscombe, Natalie J Prescott, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 6, 2018
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All
Gil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, et al.
Gastroenterology
|
February 3, 2019
Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α
Rimma Goldberg, Cristiano Scotta, Dianne Cooper, et al.
Digestive Diseases and Sciences
|
January 27, 2025
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study
Sailish Honap, Bénédicte Caron, Jacob E Ollech, et al.
The American Journal of Gastroenterology
|
July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease
Hannah K Systrom, Victoria Rai, Siddharth Singh, et al.
BMJ Open Gastroenterology
|
January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Gastroenterology
|
October 6, 2019
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial
Selina R Cox, James O Lindsay, Sébastien Fromentin, et al.
Digestive Diseases and Sciences
|
January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Gaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Nature Immunology
|
November 14, 2018
The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
Daisy Melandri, Iva Zlatareva, Raphaël A G Chaleil, et al.
Page
of 20